Article Details
Retrieved on: 2025-03-28 13:13:34
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
More than 85% of patients with small-cell lung cancer dosed with BioNTech's investigational bispecific antibody BNT327 responded to the treatment, ...
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here